GlassScriptPhysician profile
Anthony Haddad
NPI 1891174702
$4,107.71
in general payments reported to CMS, 2019-2025
13 companies · $1,345 in 2025
The $1,345 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $754 · 2022: $1,047 · 2023: $675 · 2024: $286 · 2025: $1,345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,124 · Consulting Fee: $875 · Travel and Lodging: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,123.76 |
| Consulting Fee | $875.00 |
| Travel and Lodging | $307.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,146.85 | 2023-2025 | |
| Sientra, INC. | $461.98 | 2021-2022 | |
| Davol INC. | $456.45 | 2022-2025 | Phasix Mesh |
| Merz North America, INC. | $434.11 | 2021-2023 | Xeomin |
| Becton, Dickinson and Company | $274.12 | 2023-2024 | Phasix Mesh |
| Vioptix INC | $252.97 | 2022 | |
| Tela Bio, INC. | $252.85 | 2021-2022 | |
| Innovation Technologies INC | $213.83 | 2021 | |
| Stryker Corporation | $168.80 | 2022 | |
| Lifenet Health | $152.90 | 2023 | |
| Avita Medical Americas, LLC | $145.41 | 2024 | |
| Mentor Worldwide LLC | $115.41 | 2022 | |
| Medical Device Business Services, INC. | $32.03 | 2022-2024 | Matrixcombo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Haddad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.